NEW YORK (GenomeWeb) – A team led by Boston University researchers has received a seven-year, $15.9 million grant from the National Institutes of Health to develop methods for detecting and diagnosing chronic traumatic encephalopathy (CTE).

CTE is a neurodegenerative disease characterized by the accumulation of abnormal tau protein in the brain. It is commonly associated with repetitive head injuries, such as those sustained in boxing or football, and is currently only diagnosable through post-mortem brain dissection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.